Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.

28 August 2022 (16:45 - 17:00)
Organised by:
Congress Presentation Part of: Beta3 adrenergic agonists in the clinic: the end of the beginning Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo

University Hospital Leipzig, Leipzig (Germany)

The Event

Event poster

ESC Congress 2022

28 August 2022 16:45 CET
You may be interested in